$1.03
-0.04-3.27%
At close: -
$1.05
0.021.50%
After Hours: 7:54 AM EDT
Comments
Loading...
Clearmind Medicine Analyst Ratings and Price Targets | NASDAQ:CMND | Benzinga
Clearmind Medicine Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Clearmind Medicine Corp from these most-recent analyst ratings.
Analyst Ratings for Clearmind Medicine
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Clearmind Medicine (CMND) stock?
There is no price target for Clearmind Medicine
What is the most recent analyst rating for Clearmind Medicine (CMND)?
There is no analyst for Clearmind Medicine
When was the last upgrade for Clearmind Medicine (CMND)?
There is no last upgrade for Clearmind Medicine
When was the last downgrade for Clearmind Medicine (CMND)?
There is no last downgrade for Clearmind Medicine.
When is the next analyst rating going to be posted or updated for Clearmind Medicine (CMND)?
There is no next analyst rating for Clearmind Medicine.
Is the Analyst Rating Clearmind Medicine (CMND) correct?
There is no next analyst rating for Clearmind Medicine.
Browse analyst ratings and price targets on all stocks.